TokenPost·
Regeneron Expects Mid-Teens R&D Expense Growth Rate in 2027
The company also expects to recognize Sanofi’s $1 billion upfront payment in Q4.
More news
- TokenPostLeidos Board Raises Quarterly Dividend 4.7% to $0.45 a Share
- TokenPostMeridian Corporation Board Declares $0.14 Dividend as Third-Quarter Income Falls
- TokenPostFired Adviser Sues Bank of America Over Arbitration Policy
- TokenPostFATF Says Countries Agree to Tackle Virtual-Asset Financial Crime
- TokenPostRalliant Board Approves $0.05 Quarterly Dividend for Dec. 23
- Crypto BriefingChoice launches sLINJ, a leveraged INJ staking token targeting about 12% APY